Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer.

Lung microbiota and metabolites might play important roles in the pathogenesis of lung cancer, and the altered metabolites and microbiota might have the potential to be clinical diagnostic markers and therapeutic targets associated with lung cancer.